Prognosis
AstraZeneca Clot Research Continues Amid German Theory
- German lab says it found link between vaccine and blood clots
- Research says mRNA vaccines are free from clotting dangers
Photographer: Dimas Ardian/Bloomberg
This article is for subscribers only.
AstraZeneca Plc continues to discuss the cause of rare blood clots with regulators and scientists after German researchers said they discovered the link to its Covid-19 vaccines.
The U.K. pharma company said the theory put forward by the Goethe University laboratory in Frankfurt on Wednesday is one of many that AstraZeneca scientists are investigating.